Medicine & Health News

Changes in the chromosomes of cancer cells may increase their sensitivity to anti-cancer drugs

Two complementary studies from the Faculty of Medical and Health Sciences at Tel Aviv University (TAU), in collaboration with the European Institute of Oncology in Milan, have extensively examined the characteristics of aneuploid cells, which have an abnormal number of chromosomes, and raised findings that may advance new cancer treatments. According to the researchers, “A… Read More

New TAU technology may enable early diagnosis of Parkinson’s disease

Researchers at Tel Aviv University (TAU) in cooperation with three major Israeli medical centers have developed a new method for detecting protein aggregation in cells, a hallmark of Parkinson’s disease. The technology can enable diagnosis up to 20 years before the first motor symptoms appear, facilitating treatment or even prevention of the severe disease, which… Read More

Closed-eye imaging can track pain in unresponsive patients

A new technological development from Tel Aviv University (TAU) can monitor changes in pupil size and gaze direction behind closed eyes using touchless infrared imaging. Tracking changes in pupil size can help identify a state of wakefulness in sleep, anesthesia, and intensive care and help track the depth of sedation, detect seizures and nightmares, and… Read More

Monitoring of step length can diagnose neurological diseases and aging

Researchers at Tel Aviv University (TAU) and the Ichilov’s Tel Aviv Sourasky Medical Center (Tel Aviv) have developed an interdisciplinary model based on machine learning to accurately estimate step length. The new model can be integrated into a wearable device that is attached with tape to the lower back and enables continuous monitoring of steps… Read More

TAU study reveals mechanism linking heart disease to cancer development

Researchers at Tel Aviv University (TAU) and the Leviev Cardiothoracic and Vascular Center at the Sheba Medical Center have found a mechanism responsible for increasing the risk of developing cancer among patients with heart disease. They say that small extracellular bubbles, or vesicles (sEVs), that are secreted from the sick heart to heal itself are… Read More

Existing drugs may hinder development of bone metastasis in breast cancer patients

Researchers at Tel Aviv University (TAU) have developed a new therapeutic strategy based on existing medications to inhibit bone metastasis in breast cancer patients. Using both an animal model and tissue samples from patients in Israel and the US, they demonstrated that a combination of drugs already available on the market can hinder bone metastasis… Read More

Heart patients live longer in a “greener” environment, TAU study finds

In a long-term study, researchers from Tel Aviv University (TAU) found that the survival rate of bypass surgery heart patients who live in greener areas is significantly greater than those whose living environment is devoid of greenery. The study was conducted by PhD student Maya Sadeh under the guidance of Professor Rachel Dankner from the… Read More